Xella Health raised $3.7 million in a pre‑seed round led by Precursor Ventures to develop a multiomic women's precision health and diagnostics platform combining at‑home sample collection (menstrual fluid and blood), longitudinal data analysis, and clinician‑led telemedicine. CEO Kelly Lacob said the company will use the funds to finalize product development, expand partnerships, and target a spring launch while positioning the platform to deliver earlier, personalized detection and monitoring across women's health indications.